Hair Loss Clinical Trials

A listing of Hair Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 74 clinical trials
A Study to Evaluate the Efficacy and Safety of AD-208

The purpose of this study is to evaluate the efficacy and safety of AD-208.

  • 0 views
  • 23 Nov, 2021
  • 1 location
Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia

> Hypothesis: KGF-HS will result in less than 50% hair loss by the end of 4 cycles of chemotherapy. The investigators will evaluate hair loss using the CTCAE (Common Terminology Criteria for Adverse Events

taxane
cancer
anthracycline
breast cancer
  • 30 views
  • 18 Dec, 2021
  • 1 location
Alopecia Prevention Scalp Cooling in Chinese Breast Cancer Patients

Prevention System to prevent chemotherapy-induced alopecia. This project seeks to demonstrate that the Orbis Paxman Hair Loss Prevention System is safe and effective in reducing chemotherapy-induced

  • 0 views
  • 10 Apr, 2021
  • 1 location
PBMT for the Management of CIA ( HAIRLASER )

-induced alopecia (CIA) occurs in about 65% of the patients. Hair loss due to CT is reversible, but hair regrowth requires several months to a year after CT. Currently, the only available preventive

taxane
anthracycline
treatment regimen
breast cancer
scalp cooling
  • 0 views
  • 16 Sep, 2021
  • 1 location
Tofacitinib for Immune Skin Conditions in Down Syndrome

People with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is safe and could improve associated skin conditions. The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug …

skin disorder
tofacitinib
dermatitis
areata alopecia
unbalanced translocation
  • 60 views
  • 12 Dec, 2021
  • 1 location
Using a Cold Atmospheric Plasma Device to Treat Skin Disorders

This study examines the efficacy of a non-thermal, atmospheric plasma device in the treatment of skin disorders

skin disorder
alopecia
skin disorders
skin lesion
skin lesions
  • 153 views
  • 26 Jan, 2022
  • 1 location
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients

This study is being done to determine if using the Paxman Scalp Cooling System at temperatures lower than the current standard is a safe and tolerable approach to prevent hair loss in breast

trastuzumab
cyclophosphamide
taxane
pertuzumab
breast cancer staging
  • 12 views
  • 22 Oct, 2021
  • 1 location
Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients

This study aims to examine whether the PSCS2 is effective in reducing chemotherapy-induced alopecia in woman with breast cancer undergoing neoadjuvant or adjuvant chemotherapy. Female adults who

taxane
adjuvant chemotherapy
adriamycin
  • 0 views
  • 20 Aug, 2021
  • 1 location
Scalp Cooling in Gynecologic Cancer Patients

In gynecologic cancers, many common chemotherapy agents can lead to chemotherapy-induced alopecia. Currently scalp cooling is the most well studied preventive measure. However, its acceptability

cancer
paclitaxel
ifosfamide
  • 0 views
  • 23 Jan, 2021
  • 1 location
A Study to Evaluate JAK Inhibitor Cream in EGFR-inhibitor-induced Skin Rash

any clinical trial yet. Janus kinase (JAK) inhibitor, has been approved for or studied in a variety of skin conditions such as alopecia areata, atopic dermatitis, and psoriasis. Thus the investigators

  • 0 views
  • 03 Dec, 2021
  • 1 location